n (%) | Univariate analysis HR (95% CI) | P | Multivariate analysis HR (95% CI) | P | |
---|---|---|---|---|---|
age | |||||
< 18 | 66(78.57%) | 1 (Reference) | |||
> = 18 | 18(21.43%) | 0.94 (0.36–2.5) | 0.91 | ||
Gender | |||||
female | 37(44.05%) | 1 (Reference) | |||
male | 47(55.95%) | 0.72 (0.34–1.5) | 0.39 | ||
Primary.Site | |||||
Pelvis | 2(2.38%) | ||||
Arm/hand | 6(7.14%) | ||||
Leg/Foot | 76(90.48%) | 1.579(0.15–2.70) | 0.54 | ||
Metastasis | |||||
Non metastasis | 63(75%) | 1 (Reference) | |||
Metastasis | 21&25%) | 4.7 (2.2–10) | 7.10E-05 | 6.8(3.0–15.1) | 3.42E-06 |
RiskScore | |||||
Low | 42(50%) | 1 (Reference) | |||
High | 42(50%) | 14 (4.3–48) | 1.40E-05 | 18.7(5.5–63.5) | 2.85E-06 |